Greg Keenan Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Greg Keenan is Chief Medical Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 153,484 shares of AUPH, which is worth approximately $1.25 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 8,305 shares (Common Stock) at a price of $8.23 per share, resulting in proceeds of $68,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K
n/a 3M change
n/a 12M change
Total Value Held $1.25 Million

Greg Keenan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
SELL
Open market or private sale
$68,350 $8.23 p/Share
8,305 Reduced 5.13%
153,484 Common Stock
Mar 03 2025
SELL
Open market or private sale
$97,912 $8.0 p/Share
12,239 Reduced 7.03%
161,789 Common Stock
Feb 28 2025
BUY
Grant, award, or other acquisition
-
62,583 Added 26.45%
174,028 Common Stock
GK

Greg Keenan

Chief Medical Officer
Edmonton, A0

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH